Submit request or call to make an appointment.
The best lung cancer care begins with quality research. It shapes our understanding of the disease, guides our treatments, and gives hope for the future for lung cancer patients. At Norton Cancer Institute, we are constantly seeking new ways to personalize treatment for lung cancer. Our multidisciplinary team of researchers, physicians, nurses and support staff works closely together to incorporate the newest lung cancer findings into your care. We offer promising, targeted therapies through clinical trials to give you access to new and innovative treatments before they’re widely available.
Clinical research is the study of health and illness in people. There are two main types of clinical research: observational studies and clinical trials.
Observational studies involve researchers monitoring behaviors or other information. This information is analyzed, and the results can help guide clinical trials. There are no medical interventions such as drugs or medical devices during observational studies.
Clinical trials test medical, surgical or behavioral interventions. This is the most common way to see if a drug, device, diet or other kind of disease prevention or treatment is safe and effective for people.
Some other goals of lung cancer clinical trials include:
There are many reasons you might want to be part of a lung cancer clinical study, including wanting to be part of discovering health information that may help others in the future — and feeling like you are playing a more active role in your health.
You may have tried all the available treatment options for your lung cancer, and they have not been effective.
Whatever the motivation, when you choose to participate in a clinical trial, you become a partner in scientific discovery. Your participation in research can help future generations lead healthier lives. Major medical breakthroughs could not happen without the generosity of clinical trial participants — young and old, healthy, or diagnosed with a disease.
Norton Cancer Institute is at the forefront of lung cancer treatment research in this region. As investigators on numerous lung cancer clinical trials, our specialist physicians have extensive experience with many innovative treatments once they are approved for broad use. Patients also may be eligible to take part in these experimental lung cancer treatments. Norton Cancer Institute researchers also contribute to groundbreaking studies and publications in peer-reviewed journals.
Our current lung cancer clinical trials include:
Learn more about participating in a clinical trial at Norton Healthcare.